Description

This index is designed to track the financial performance of large and medium-sized corporations based in developed European nations, exclusively within the healthcare industry, according to the Global Industry Classification Standard (GICS) taxonomy. Constituents are weighted based on their free-float adjusted market capitalization; however, to maintain diversification, weight limits are imposed: the maximum allocation for any single corporate group is 35%, with all other associated entities restricted to 20%. These limits incorporate a 10% buffer during scheduled index rebalancings, alongside further monthly ad-hoc adjustments when necessary. A stringent screening process removes companies that fail to meet predefined environmental, social, and governance (ESG) criteria. This includes those associated with controversial weaponry, possessing an MSCI ESG Rating of 'CCC' or lacking a rating, or deriving significant income from tobacco, conventional or nuclear arms, civilian firearms, thermal coal, unconventional or Arctic oil and gas extraction, or palm oil. Any issuer with an MSCI Controversies Score of 0 is also ineligible. Furthermore, it is structured to achieve a reduced greenhouse gas intensity relative to its broader benchmark index.